Friday, 18 September 2026 08:45 PM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / September 18, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ:ASTH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Astrana and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On September 17, 2026, Glass House Research published a short report alleging that Astrana's growth relies on aggressive acquisitions and subjective management estimates rather than organic expansion, as well as citing concerns over a $545 million related-party loan and 2027 Medicare regulatory exposure.
Following publication of the report, Astrana's stock price fell $3.40 per share, or 9.02%, to close at $34.30 per share on September 17, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Pomerantz LLP